Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ovation Pharmaceuticals

2000 FOUNDED
M&A STATUS
201-300 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer, manufacturer and distributor of medically necessary prescription pharmaceuticals for under served, focused patient groups. The company offers late-stage CNS/epilepsy pipelines, as well as clinical development programs. Its areas of focus include CNS, hematology/oncology, and hospital products. It also acquires under-marketed pharmaceutical products for concentrated physician specialty markets that can benefit from the company's sales and marketing expertise.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 4 Parkway North
  • Suite 200
  • Deerfield, IL 60015
  • United States

+1 (847) 000-0000

Ovation Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Ovation Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Ovation Pharmaceuticals Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Ovation Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Ovation Pharmaceuticals Executive Team (7)

Name Title Board
Seat
Contact
Info
Robert Holt Vice President, Medical Affairs
Marc Wipperman Vice President, Operations

5 Former Executives

You’re viewing 2 of 7 executives. Get the full list »